A PHP Error was encountered

Severity: Warning

Message: fopen(/var/cpanel/php/sessions/ea-php72/ci_session276fcec38e69187e20c056cd3899438bcfae8d1c): failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 176

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/cpanel/php/sessions/ea-php72)

Filename: Session/Session.php

Line Number: 143

Backtrace:

File: /home/rejovjcx/mraccuracyreports.com/application/controllers/Reportdetails.php
Line: 10
Function: library

File: /home/rejovjcx/mraccuracyreports.com/index.php
Line: 315
Function: require_once

Global Obesity Treatment Market Insights, Forecast to 2034

img

Global Obesity Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global Obesity Treatment Market Insights, Forecast to 2034

Obesity is a major health problem worldwide responsible for increased morbidity/mortality and high cost for the society. Management of obesity requires multidisciplinary approaches including diet, food supplement, exercise, behavior change, drug, medical device, gut microbiome manipulation, and surgery. Anti-obesity medical devices are an option for subjects who have not responded to more conservative medical treatments but want an alternative to surgery.
Market Analysis and InsightsGlobal Obesity Treatment Market
Global Obesity Treatment market is expected to reach to US$ 6361.7 million in 2023, with a positive growth of %, compared with US$ 5452.1 million in 2022. Backed with the increasing demand from downstream industries, Obesity Treatment industry is evaluated to reach US$ 13530 million in 2033. The CAGR will be 13.4% during 2023 to 2033.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Obesity Treatment market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Obesity Treatment market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


NutriSystem, Inc. (U.S.)
Kellogg Company (U.S.)
Ethicon, Inc. (U.S.)
Medtronic (U.S.)
F. Hoffmann-La Roche (Switzerland)
Atkins Nutritionals, Inc. (U.S.)
Herbalife Ltd. (U.S.)
Covidien plc (U.S.)
Apollo Endosurgery (U.S.)
Amer Sports (Finland)
Johnson Health Technology, Ltd. (Taiwan)
Cybex International (U.S.)
USGI Medical (U.S.)
Olympus Corporation (Japan)
Brunswick Corporation (U.S.)
Technogym SpA (Italy)
Segment by Type
Surgical & Implant Devices
Medication Therapy
Dietary
Other

Segment by Application


Children
Adults
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, Obesity Treatment introduction, etc. Obesity Treatment Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of Obesity Treatment
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Obesity Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Surgical & Implant Devices
1.2.3 Medication Therapy
1.2.4 Dietary
1.2.5 Other
1.3 Market by Application
1.3.1 Global Obesity Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Children
1.3.3 Adults
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Obesity Treatment Market Perspective (2018-2033)
2.2 Global Obesity Treatment Growth Trends by Region
2.2.1 Obesity Treatment Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Obesity Treatment Historic Market Size by Region (2018-2023)
2.2.3 Obesity Treatment Forecasted Market Size by Region (2024-2033)
2.3 Obesity Treatment Market Dynamics
2.3.1 Obesity Treatment Industry Trends
2.3.2 Obesity Treatment Market Drivers
2.3.3 Obesity Treatment Market Challenges
2.3.4 Obesity Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Obesity Treatment by Players
3.1.1 Global Obesity Treatment Revenue by Players (2018-2023)
3.1.2 Global Obesity Treatment Revenue Market Share by Players (2018-2023)
3.2 Global Obesity Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Obesity Treatment, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Obesity Treatment Market Concentration Ratio
3.4.1 Global Obesity Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Obesity Treatment Revenue in 2022
3.5 Global Key Players of Obesity Treatment Head office and Area Served
3.6 Global Key Players of Obesity Treatment, Product and Application
3.7 Global Key Players of Obesity Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Obesity Treatment Breakdown Data by Type
4.1 Global Obesity Treatment Historic Market Size by Type (2018-2023)
4.2 Global Obesity Treatment Forecasted Market Size by Type (2024-2033)
5 Obesity Treatment Breakdown Data by Application
5.1 Global Obesity Treatment Historic Market Size by Application (2018-2023)
5.2 Global Obesity Treatment Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Obesity Treatment Market Size (2018-2033)
6.2 North America Obesity Treatment Market Size by Type
6.2.1 North America Obesity Treatment Market Size by Type (2018-2023)
6.2.2 North America Obesity Treatment Market Size by Type (2024-2033)
6.2.3 North America Obesity Treatment Market Share by Type (2018-2033)
6.3 North America Obesity Treatment Market Size by Application
6.3.1 North America Obesity Treatment Market Size by Application (2018-2023)
6.3.2 North America Obesity Treatment Market Size by Application (2024-2033)
6.3.3 North America Obesity Treatment Market Share by Application (2018-2033)
6.4 North America Obesity Treatment Market Size by Country
6.4.1 North America Obesity Treatment Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America Obesity Treatment Market Size by Country (2018-2023)
6.4.3 North America Obesity Treatment Market Size by Country (2024-2033)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Obesity Treatment Market Size (2018-2033)
7.2 Europe Obesity Treatment Market Size by Type
7.2.1 Europe Obesity Treatment Market Size by Type (2018-2023)
7.2.2 Europe Obesity Treatment Market Size by Type (2024-2033)
7.2.3 Europe Obesity Treatment Market Share by Type (2018-2033)
7.3 Europe Obesity Treatment Market Size by Application
7.3.1 Europe Obesity Treatment Market Size by Application (2018-2023)
7.3.2 Europe Obesity Treatment Market Size by Application (2024-2033)
7.3.3 Europe Obesity Treatment Market Share by Application (2018-2033)
7.4 Europe Obesity Treatment Market Size by Country
7.4.1 Europe Obesity Treatment Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe Obesity Treatment Market Size by Country (2018-2023)
7.4.3 Europe Obesity Treatment Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Obesity Treatment Market Size (2018-2033)
8.2 China Obesity Treatment Market Size by Type
8.2.1 China Obesity Treatment Market Size by Type (2018-2023)
8.2.2 China Obesity Treatment Market Size by Type (2024-2033)
8.2.3 China Obesity Treatment Market Share by Type (2018-2033)
8.3 China Obesity Treatment Market Size by Application
8.3.1 China Obesity Treatment Market Size by Application (2018-2023)
8.3.2 China Obesity Treatment Market Size by Application (2024-2033)
8.3.3 China Obesity Treatment Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia Obesity Treatment Market Size (2018-2033)
9.2 Asia Obesity Treatment Market Size by Type
9.2.1 Asia Obesity Treatment Market Size by Type (2018-2023)
9.2.2 Asia Obesity Treatment Market Size by Type (2024-2033)
9.2.3 Asia Obesity Treatment Market Share by Type (2018-2033)
9.3 Asia Obesity Treatment Market Size by Application
9.3.1 Asia Obesity Treatment Market Size by Application (2018-2023)
9.3.2 Asia Obesity Treatment Market Size by Application (2024-2033)
9.3.3 Asia Obesity Treatment Market Share by Application (2018-2033)
9.4 Asia Obesity Treatment Market Size by Region
9.4.1 Asia Obesity Treatment Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia Obesity Treatment Market Size by Region (2018-2023)
9.4.3 Asia Obesity Treatment Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Obesity Treatment Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America Obesity Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Obesity Treatment Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Obesity Treatment Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America Obesity Treatment Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America Obesity Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Obesity Treatment Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Obesity Treatment Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America Obesity Treatment Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America Obesity Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Obesity Treatment Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America Obesity Treatment Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Obesity Treatment Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 NutriSystem, Inc. (U.S.)
11.1.1 NutriSystem, Inc. (U.S.) Company Details
11.1.2 NutriSystem, Inc. (U.S.) Business Overview
11.1.3 NutriSystem, Inc. (U.S.) Obesity Treatment Introduction
11.1.4 NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.1.5 NutriSystem, Inc. (U.S.) Recent Developments
11.2 Kellogg Company (U.S.)
11.2.1 Kellogg Company (U.S.) Company Details
11.2.2 Kellogg Company (U.S.) Business Overview
11.2.3 Kellogg Company (U.S.) Obesity Treatment Introduction
11.2.4 Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.2.5 Kellogg Company (U.S.) Recent Developments
11.3 Ethicon, Inc. (U.S.)
11.3.1 Ethicon, Inc. (U.S.) Company Details
11.3.2 Ethicon, Inc. (U.S.) Business Overview
11.3.3 Ethicon, Inc. (U.S.) Obesity Treatment Introduction
11.3.4 Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.3.5 Ethicon, Inc. (U.S.) Recent Developments
11.4 Medtronic (U.S.)
11.4.1 Medtronic (U.S.) Company Details
11.4.2 Medtronic (U.S.) Business Overview
11.4.3 Medtronic (U.S.) Obesity Treatment Introduction
11.4.4 Medtronic (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.4.5 Medtronic (U.S.) Recent Developments
11.5 F. Hoffmann-La Roche (Switzerland)
11.5.1 F. Hoffmann-La Roche (Switzerland) Company Details
11.5.2 F. Hoffmann-La Roche (Switzerland) Business Overview
11.5.3 F. Hoffmann-La Roche (Switzerland) Obesity Treatment Introduction
11.5.4 F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2018-2023)
11.5.5 F. Hoffmann-La Roche (Switzerland) Recent Developments
11.6 Atkins Nutritionals, Inc. (U.S.)
11.6.1 Atkins Nutritionals, Inc. (U.S.) Company Details
11.6.2 Atkins Nutritionals, Inc. (U.S.) Business Overview
11.6.3 Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Introduction
11.6.4 Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.6.5 Atkins Nutritionals, Inc. (U.S.) Recent Developments
11.7 Herbalife Ltd. (U.S.)
11.7.1 Herbalife Ltd. (U.S.) Company Details
11.7.2 Herbalife Ltd. (U.S.) Business Overview
11.7.3 Herbalife Ltd. (U.S.) Obesity Treatment Introduction
11.7.4 Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.7.5 Herbalife Ltd. (U.S.) Recent Developments
11.8 Covidien plc (U.S.)
11.8.1 Covidien plc (U.S.) Company Details
11.8.2 Covidien plc (U.S.) Business Overview
11.8.3 Covidien plc (U.S.) Obesity Treatment Introduction
11.8.4 Covidien plc (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.8.5 Covidien plc (U.S.) Recent Developments
11.9 Apollo Endosurgery (U.S.)
11.9.1 Apollo Endosurgery (U.S.) Company Details
11.9.2 Apollo Endosurgery (U.S.) Business Overview
11.9.3 Apollo Endosurgery (U.S.) Obesity Treatment Introduction
11.9.4 Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.9.5 Apollo Endosurgery (U.S.) Recent Developments
11.10 Amer Sports (Finland)
11.10.1 Amer Sports (Finland) Company Details
11.10.2 Amer Sports (Finland) Business Overview
11.10.3 Amer Sports (Finland) Obesity Treatment Introduction
11.10.4 Amer Sports (Finland) Revenue in Obesity Treatment Business (2018-2023)
11.10.5 Amer Sports (Finland) Recent Developments
11.11 Johnson Health Technology, Ltd. (Taiwan)
11.11.1 Johnson Health Technology, Ltd. (Taiwan) Company Details
11.11.2 Johnson Health Technology, Ltd. (Taiwan) Business Overview
11.11.3 Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Introduction
11.11.4 Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2018-2023)
11.11.5 Johnson Health Technology, Ltd. (Taiwan) Recent Developments
11.12 Cybex International (U.S.)
11.12.1 Cybex International (U.S.) Company Details
11.12.2 Cybex International (U.S.) Business Overview
11.12.3 Cybex International (U.S.) Obesity Treatment Introduction
11.12.4 Cybex International (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.12.5 Cybex International (U.S.) Recent Developments
11.13 USGI Medical (U.S.)
11.13.1 USGI Medical (U.S.) Company Details
11.13.2 USGI Medical (U.S.) Business Overview
11.13.3 USGI Medical (U.S.) Obesity Treatment Introduction
11.13.4 USGI Medical (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.13.5 USGI Medical (U.S.) Recent Developments
11.14 Olympus Corporation (Japan)
11.14.1 Olympus Corporation (Japan) Company Details
11.14.2 Olympus Corporation (Japan) Business Overview
11.14.3 Olympus Corporation (Japan) Obesity Treatment Introduction
11.14.4 Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2018-2023)
11.14.5 Olympus Corporation (Japan) Recent Developments
11.15 Brunswick Corporation (U.S.)
11.15.1 Brunswick Corporation (U.S.) Company Details
11.15.2 Brunswick Corporation (U.S.) Business Overview
11.15.3 Brunswick Corporation (U.S.) Obesity Treatment Introduction
11.15.4 Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2018-2023)
11.15.5 Brunswick Corporation (U.S.) Recent Developments
11.16 Technogym SpA (Italy)
11.16.1 Technogym SpA (Italy) Company Details
11.16.2 Technogym SpA (Italy) Business Overview
11.16.3 Technogym SpA (Italy) Obesity Treatment Introduction
11.16.4 Technogym SpA (Italy) Revenue in Obesity Treatment Business (2018-2023)
11.16.5 Technogym SpA (Italy) Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Obesity Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Surgical & Implant Devices
Table 3. Key Players of Medication Therapy
Table 4. Key Players of Dietary
Table 5. Key Players of Other
Table 6. Global Obesity Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 7. Global Obesity Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Obesity Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Obesity Treatment Market Share by Region (2018-2023)
Table 10. Global Obesity Treatment Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Obesity Treatment Market Share by Region (2024-2033)
Table 12. Obesity Treatment Market Trends
Table 13. Obesity Treatment Market Drivers
Table 14. Obesity Treatment Market Challenges
Table 15. Obesity Treatment Market Restraints
Table 16. Global Obesity Treatment Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Obesity Treatment Revenue Share by Players (2018-2023)
Table 18. Global Top Obesity Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2022)
Table 19. Global Obesity Treatment Industry Ranking 2021 VS 2022 VS 2023
Table 20. Global 5 Largest Players Market Share by Obesity Treatment Revenue (CR5 and HHI) & (2018-2023)
Table 21. Global Key Players of Obesity Treatment, Headquarters and Area Served
Table 22. Global Key Players of Obesity Treatment, Product and Application
Table 23. Global Key Players of Obesity Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Obesity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Obesity Treatment Revenue Market Share by Type (2018-2023)
Table 27. Global Obesity Treatment Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Obesity Treatment Revenue Market Share by Type (2024-2033)
Table 29. Global Obesity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Obesity Treatment Revenue Share by Application (2018-2023)
Table 31. Global Obesity Treatment Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Obesity Treatment Revenue Share by Application (2024-2033)
Table 33. North America Obesity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 34. North America Obesity Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 35. North America Obesity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 36. North America Obesity Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 37. North America Obesity Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. North America Obesity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Obesity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 40. Europe Obesity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 41. Europe Obesity Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 42. Europe Obesity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 43. Europe Obesity Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 44. Europe Obesity Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 45. Europe Obesity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 46. Europe Obesity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 47. China Obesity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 48. China Obesity Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 49. China Obesity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 50. China Obesity Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 51. Asia Obesity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 52. Asia Obesity Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 53. Asia Obesity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 54. Asia Obesity Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 55. Asia Obesity Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 56. Asia Obesity Treatment Market Size by Region (2018-2023) & (US$ Million)
Table 57. Asia Obesity Treatment Market Size by Region (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Obesity Treatment Market Size by Type (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Obesity Treatment Market Size by Type (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Obesity Treatment Market Size by Application (2018-2023) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Obesity Treatment Market Size by Application (2024-2033) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Obesity Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 63. Middle East, Africa, and Latin America Obesity Treatment Market Size by Country (2018-2023) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Obesity Treatment Market Size by Country (2024-2033) & (US$ Million)
Table 65. NutriSystem, Inc. (U.S.) Company Details
Table 66. NutriSystem, Inc. (U.S.) Business Overview
Table 67. NutriSystem, Inc. (U.S.) Obesity Treatment Product
Table 68. NutriSystem, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 69. NutriSystem, Inc. (U.S.) Recent Developments
Table 70. Kellogg Company (U.S.) Company Details
Table 71. Kellogg Company (U.S.) Business Overview
Table 72. Kellogg Company (U.S.) Obesity Treatment Product
Table 73. Kellogg Company (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 74. Kellogg Company (U.S.) Recent Developments
Table 75. Ethicon, Inc. (U.S.) Company Details
Table 76. Ethicon, Inc. (U.S.) Business Overview
Table 77. Ethicon, Inc. (U.S.) Obesity Treatment Product
Table 78. Ethicon, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 79. Ethicon, Inc. (U.S.) Recent Developments
Table 80. Medtronic (U.S.) Company Details
Table 81. Medtronic (U.S.) Business Overview
Table 82. Medtronic (U.S.) Obesity Treatment Product
Table 83. Medtronic (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 84. Medtronic (U.S.) Recent Developments
Table 85. F. Hoffmann-La Roche (Switzerland) Company Details
Table 86. F. Hoffmann-La Roche (Switzerland) Business Overview
Table 87. F. Hoffmann-La Roche (Switzerland) Obesity Treatment Product
Table 88. F. Hoffmann-La Roche (Switzerland) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 89. F. Hoffmann-La Roche (Switzerland) Recent Developments
Table 90. Atkins Nutritionals, Inc. (U.S.) Company Details
Table 91. Atkins Nutritionals, Inc. (U.S.) Business Overview
Table 92. Atkins Nutritionals, Inc. (U.S.) Obesity Treatment Product
Table 93. Atkins Nutritionals, Inc. (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 94. Atkins Nutritionals, Inc. (U.S.) Recent Developments
Table 95. Herbalife Ltd. (U.S.) Company Details
Table 96. Herbalife Ltd. (U.S.) Business Overview
Table 97. Herbalife Ltd. (U.S.) Obesity Treatment Product
Table 98. Herbalife Ltd. (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 99. Herbalife Ltd. (U.S.) Recent Developments
Table 100. Covidien plc (U.S.) Company Details
Table 101. Covidien plc (U.S.) Business Overview
Table 102. Covidien plc (U.S.) Obesity Treatment Product
Table 103. Covidien plc (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 104. Covidien plc (U.S.) Recent Developments
Table 105. Apollo Endosurgery (U.S.) Company Details
Table 106. Apollo Endosurgery (U.S.) Business Overview
Table 107. Apollo Endosurgery (U.S.) Obesity Treatment Product
Table 108. Apollo Endosurgery (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 109. Apollo Endosurgery (U.S.) Recent Developments
Table 110. Amer Sports (Finland) Company Details
Table 111. Amer Sports (Finland) Business Overview
Table 112. Amer Sports (Finland) Obesity Treatment Product
Table 113. Amer Sports (Finland) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 114. Amer Sports (Finland) Recent Developments
Table 115. Johnson Health Technology, Ltd. (Taiwan) Company Details
Table 116. Johnson Health Technology, Ltd. (Taiwan) Business Overview
Table 117. Johnson Health Technology, Ltd. (Taiwan) Obesity Treatment Product
Table 118. Johnson Health Technology, Ltd. (Taiwan) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 119. Johnson Health Technology, Ltd. (Taiwan) Recent Developments
Table 120. Cybex International (U.S.) Company Details
Table 121. Cybex International (U.S.) Business Overview
Table 122. Cybex International (U.S.) Obesity Treatment Product
Table 123. Cybex International (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 124. Cybex International (U.S.) Recent Developments
Table 125. USGI Medical (U.S.) Company Details
Table 126. USGI Medical (U.S.) Business Overview
Table 127. USGI Medical (U.S.) Obesity Treatment Product
Table 128. USGI Medical (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 129. USGI Medical (U.S.) Recent Developments
Table 130. Olympus Corporation (Japan) Company Details
Table 131. Olympus Corporation (Japan) Business Overview
Table 132. Olympus Corporation (Japan) Obesity Treatment Product
Table 133. Olympus Corporation (Japan) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 134. Olympus Corporation (Japan) Recent Developments
Table 135. Brunswick Corporation (U.S.) Company Details
Table 136. Brunswick Corporation (U.S.) Business Overview
Table 137. Brunswick Corporation (U.S.) Obesity Treatment Product
Table 138. Brunswick Corporation (U.S.) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 139. Brunswick Corporation (U.S.) Recent Developments
Table 140. Technogym SpA (Italy) Company Details
Table 141. Technogym SpA (Italy) Business Overview
Table 142. Technogym SpA (Italy) Obesity Treatment Product
Table 143. Technogym SpA (Italy) Revenue in Obesity Treatment Business (2018-2023) & (US$ Million)
Table 144. Technogym SpA (Italy) Recent Developments
Table 145. Research Programs/Design for This Report
Table 146. Key Data Information from Secondary Sources
Table 147. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Obesity Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global Obesity Treatment Market Share by Type: 2022 VS 2033
Figure 3. Surgical & Implant Devices Features
Figure 4. Medication Therapy Features
Figure 5. Dietary Features
Figure 6. Other Features
Figure 7. Global Obesity Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 8. Global Obesity Treatment Market Share by Application: 2022 VS 2033
Figure 9. Children Case Studies
Figure 10. Adults Case Studies
Figure 11. Obesity Treatment Report Years Considered
Figure 12. Global Obesity Treatment Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 13. Global Obesity Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 14. Global Obesity Treatment Market Share by Region: 2022 VS 2033
Figure 15. Global Obesity Treatment Market Share by Players in 2022
Figure 16. Global Top Obesity Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Obesity Treatment as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Obesity Treatment Revenue in 2022
Figure 18. North America Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 19. North America Obesity Treatment Market Share by Type (2018-2033)
Figure 20. North America Obesity Treatment Market Share by Application (2018-2033)
Figure 21. North America Obesity Treatment Market Share by Country (2018-2033)
Figure 22. United States Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Obesity Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 25. Europe Obesity Treatment Market Share by Type (2018-2033)
Figure 26. Europe Obesity Treatment Market Share by Application (2018-2033)
Figure 27. Europe Obesity Treatment Market Share by Country (2018-2033)
Figure 28. Germany Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. France Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. U.K. Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Italy Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Russia Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Nordic Countries Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. China Obesity Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 35. China Obesity Treatment Market Share by Type (2018-2033)
Figure 36. China Obesity Treatment Market Share by Application (2018-2033)
Figure 37. Asia Obesity Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 38. Asia Obesity Treatment Market Share by Type (2018-2033)
Figure 39. Asia Obesity Treatment Market Share by Application (2018-2033)
Figure 40. Asia Obesity Treatment Market Share by Region (2018-2033)
Figure 41. Japan Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. South Korea Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. China Taiwan Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Southeast Asia Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. India Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Australia Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Obesity Treatment Market Size YoY (2018-2033) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Obesity Treatment Market Share by Type (2018-2033)
Figure 49. Middle East, Africa, and Latin America Obesity Treatment Market Share by Application (2018-2033)
Figure 50. Middle East, Africa, and Latin America Obesity Treatment Market Share by Country (2018-2033)
Figure 51. Brazil Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 52. Mexico Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 53. Turkey Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Saudi Arabia Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Israel Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. GCC Countries Obesity Treatment Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. NutriSystem, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 58. Kellogg Company (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 59. Ethicon, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 60. Medtronic (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 61. F. Hoffmann-La Roche (Switzerland) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 62. Atkins Nutritionals, Inc. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 63. Herbalife Ltd. (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 64. Covidien plc (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 65. Apollo Endosurgery (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 66. Amer Sports (Finland) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 67. Johnson Health Technology, Ltd. (Taiwan) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 68. Cybex International (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 69. USGI Medical (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 70. Olympus Corporation (Japan) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 71. Brunswick Corporation (U.S.) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 72. Technogym SpA (Italy) Revenue Growth Rate in Obesity Treatment Business (2018-2023)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries